INmune Bio Co-Founder and CEO RJ Tesi Presents at Cambridge Healthcare Institute?s 7th Annual Immuno-Oncology Summit

LA JOLLA, Calif., Aug. 01, 2019 (GLOBE NEWSWIRE) — INmune Bio, Inc. (NASDAQ: INMB), an immunology company focused on developing treatments that harness the patient?s innate immune system to fight disease, today announced that RJ Tesi, M.D., co-founder and CEO, will present at the Cambridge Healthcare Institute?s 7th Annual Immuno-Oncology Summit, taking place in Boston from Aug. 5 through Aug. 9.

Click to view original post

Advertise With Us